In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 29th, 2005 | 23 | Yes |
Popular Name: Tofacitinib citrate Tofacitinib citrate
Find On: PubMed — Wikipedia — Google
CAS Numbers: 212143-23-2 , 477600-75-2 , 540737-29-9 , 916591-01-0 , [477600-75-2] , [540737-29-9]
477600-75-2; D09970; Tasocitinib; Tofacitinib (USAN)
540737-29-9; D09783; Tasocitinib citrate; Tofacitinib citrate (JAN/USAN); Xeljanz (TN)
550; CP-690; CP-690550; CP-690550-10
CP-690,550-10; Tasocitinib citrate
CP-690; CP-690550; CP-690550-10
Tofacitinib (CP-690550, Tasocitinib)
Tofacitinib (USAN); Tofacitinib Citrate (USAN)
Tofacitinib citrate (CP-690550 citrate)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 0.45 | 9.01 | -25.29 | 1 | 7 | 0 | 89 | 312.377 | 3 | ↓ |
Mid Mid (pH 6-8) | -0.01 | 6.74 | -49.17 | 1 | 7 | 1 | 86 | 313.385 | 3 | ↓ |
Lo Low (pH 4.5-6) | 0.45 | 9.48 | -43.37 | 2 | 7 | 1 | 90 | 313.385 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.99e-01 g/l | DrugBank-experimental |
Target | JAK | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
DCLK3-1-E | Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.51 | Binding ≤ 10μM |
JAK1-1-E | Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.50 | Binding ≤ 10μM |
JAK2-1-E | Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.51 | Binding ≤ 10μM |
JAK3-2-E | Tyrosine-protein Kinase JAK3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 48 | 0.45 | Binding ≤ 10μM |
KCC1A-1-E | CaM Kinase I Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5000 | 0.32 | Binding ≤ 10μM |
KS6A2-1-E | Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1400 | 0.36 | Binding ≤ 10μM |
KS6A6-1-E | Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.36 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 3870 | 0.33 | Binding ≤ 10μM |
NUAK2-1-E | NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 420 | 0.39 | Binding ≤ 10μM |
PKN1-1-E | Protein Kinase N1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 200 | 0.41 | Binding ≤ 10μM |
ROCK2-2-E | Rho-associated Protein Kinase 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3400 | 0.33 | Binding ≤ 10μM |
STK3-1-E | Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4300 | 0.33 | Binding ≤ 10μM |
TNK1-1-E | Non-receptor Tyrosine-protein Kinase TNK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 640 | 0.38 | Binding ≤ 10μM |
TYK2-1-E | Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.38 | Binding ≤ 10μM |
Z80036-1-O | BaF3 (IL-3-dependent Pro-B-cells) (cluster #1 Of 3), Other | Other | 570 | 0.38 | Functional ≤ 10μM |
Z81072-1-O | Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other | Other | 7840 | 0.31 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TNK1_HUMAN | Q13470 | Non-receptor Tyrosine-protein Kinase TNK1, Human | 640 | 0.38 | Binding ≤ 1μM |
NUAK2_HUMAN | Q9H093 | NUAK Family SNF1-like Kinase 2, Human | 420 | 0.39 | Binding ≤ 1μM |
PKN1_HUMAN | Q16512 | Protein Kinase N1, Human | 200 | 0.41 | Binding ≤ 1μM |
DCLK3_HUMAN | Q9C098 | Serine/threonine-protein Kinase DCLK3, Human | 4.5 | 0.51 | Binding ≤ 1μM |
JAK1_HUMAN | P23458 | Tyrosine-protein Kinase JAK1, Human | 1.7 | 0.53 | Binding ≤ 1μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1.6 | 0.54 | Binding ≤ 1μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 0.7 | 0.56 | Binding ≤ 1μM |
JAK3_MOUSE | Q62137 | Tyrosine-protein Kinase JAK3, Mouse | 48 | 0.45 | Binding ≤ 1μM |
TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 176 | 0.41 | Binding ≤ 1μM |
KCC1A_HUMAN | Q14012 | CaM Kinase I Alpha, Human | 5000 | 0.32 | Binding ≤ 10μM |
TNK1_HUMAN | Q13470 | Non-receptor Tyrosine-protein Kinase TNK1, Human | 640 | 0.38 | Binding ≤ 10μM |
NUAK2_HUMAN | Q9H093 | NUAK Family SNF1-like Kinase 2, Human | 420 | 0.39 | Binding ≤ 10μM |
PKN1_HUMAN | Q16512 | Protein Kinase N1, Human | 200 | 0.41 | Binding ≤ 10μM |
ROCK2_HUMAN | O75116 | Rho-associated Protein Kinase 2, Human | 3400 | 0.33 | Binding ≤ 10μM |
KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 1400 | 0.36 | Binding ≤ 10μM |
KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 1200 | 0.36 | Binding ≤ 10μM |
DCLK3_HUMAN | Q9C098 | Serine/threonine-protein Kinase DCLK3, Human | 4.5 | 0.51 | Binding ≤ 10μM |
STK3_HUMAN | Q13188 | Serine/threonine-protein Kinase MST2, Human | 4300 | 0.33 | Binding ≤ 10μM |
JAK1_HUMAN | P23458 | Tyrosine-protein Kinase JAK1, Human | 1.7 | 0.53 | Binding ≤ 10μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1.6 | 0.54 | Binding ≤ 10μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 0.7 | 0.56 | Binding ≤ 10μM |
JAK3_MOUSE | Q62137 | Tyrosine-protein Kinase JAK3, Mouse | 48 | 0.45 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 1800 | 0.35 | Binding ≤ 10μM |
TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 176 | 0.41 | Binding ≤ 10μM |
Z80036 | Z80036 | BaF3 (IL-3-dependent Pro-B-cells) | 1574 | 0.35 | Functional ≤ 10μM |
Z81072 | Z81072 | Jurkat (Acute Leukemic T-cells) | 7840 | 0.31 | Functional ≤ 10μM |
Description | Species |
---|---|
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation | |
CREB phosphorylation through the activation of Ras | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
Downstream TCR signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
ERK/MAPK targets | |
Factors involved in megakaryocyte development and platelet production | |
G alpha (12/13) signalling events | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Generation of second messenger molecules | |
GPVI-mediated activation cascade | |
Growth hormone receptor signaling | |
Interferon alpha/beta signaling | |
Interferon gamma signaling | |
Interleukin receptor SHC signaling | |
Interleukin-2 signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
Interleukin-6 signaling | |
Interleukin-7 signaling | |
ISG15 antiviral mechanism | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PIP3 activates AKT signaling | |
Prolactin receptor signaling | |
Recycling pathway of L1 | |
Regulation of IFNA signaling | |
Regulation of IFNG signaling | |
Regulation of KIT signaling | |
RMTs methylate histone arginines | |
RSK activation | |
Sema4D induced cell migration and growth-cone collapse | |
Senescence-Associated Secretory Phenotype (SASP) | |
Signaling by Hippo | |
Signaling by Leptin | |
Signaling by SCF-KIT | |
Translocation of ZAP-70 to Immunological synapse | |
VEGFA-VEGFR2 Pathway |